NAD+ Dosage Chart
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to cellular energy metabolism, DNA repair, and sirtuin activity. Research and clinic protocols explore subcutaneous micro-dosing and slow intravenous administration for metabolic and longevity contexts.
Half-life
Variable (rapidly metabolised; delivered as a bolus or drip)
Format
Injectable
Purity
≥98%
Protocols
3 variants
Research Protocols
Dosage Protocols
Each row reflects a common research protocol variant. These are reference ranges derived from published literature and community research — not medical guidance.
Protocol 1
Subcutaneous Micro-Dose Protocol
Dose
50-100mg once daily
Duration
2-4 weeks, then reassess
Small subcutaneous doses are used because NAD+ injection can sting and cause a flushing sensation. Inject slowly. Start at the low end.
Protocol 2
Intravenous Drip Protocol
Dose
250-500mg as a slow IV infusion
Duration
1-2 times per week
IV NAD+ must be infused slowly (often over 1-2+ hours); rapid administration causes chest tightness, nausea, and flushing. Clinical-setting protocol only.
Protocol 3
Maintenance Protocol
Dose
50mg subcutaneous 2-3 times per week
Duration
Ongoing (cycled)
Lower-frequency subcutaneous dosing after an initial phase. Often paired with NAD+ precursors like NMN in longevity research.
Mixing Math
Reconstitution
Reference values for preparing a research vial. Adjust the syringe reading if you change the water volume.
Vial size
1000mg vial
BAC water
5ml bacteriostatic water
Concentration
200mg/ml
Dose / ml
50mg = 0.25ml · 100mg = 0.5ml
Syringe units
25 IU (50mg) · 50 IU (100mg) on a U-100 syringe
Frequently Paired
Common Stacks
Storage
Handling Notes
Lyophilized: 2-8°C preferred, -20°C for extended storage. Reconstituted: refrigerate at 2-8°C and use within about 28 days. Protect from light. NAD+ solutions degrade faster than many peptides; prepare conservatively.
Research Considerations
Cautions
- Rapid administration is the main issue: inject subcutaneous doses slowly and infuse IV over an extended period to avoid chest tightness, nausea, and flushing.
- NAD+ is a research compound in injectable form and is not an approved drug; source only COA-verified material.
- Benefits for longevity endpoints in humans remain largely unproven; most evidence is mechanistic or preclinical.
Ready to start your research
Get NAD+ from Ascension Peptides
COA-verified, US-based, discreet shipping. Use code ENHANCED for 50% off your entire order.
Buy NAD+ nowResearch use only. Not medical advice. Browse all dosage charts